FDA grants Investigational Device Exemption for MINIject in glaucoma patients
July 15, 2021
According to iSTAR Medical, the STAR-V study will investigate the device in 350 patients with primary open angle glaucoma.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Glaucoma Insights
Study: Gene therapy could preserve vision in patients with retinal disease, serious retinal injury
July 28, 2021
Investigators uncovered evidence that CaMKII could prove to be a desirable therapeutic target for vision preservation in conditions that damage the axons and somas of retinal ganglion cells.
Studying glaucoma epidemiology at the center of the Earth
January 30, 2021
Donald L. Budenz, MD, MPH, shares the key takeaways from his Shaffer-Hetherington-Hoskins Lecture, focusing on glaucoma epidemiology, presented during the 2021 Glaucoma 360's 25th Annual Glaucoma Symposium CME.
Effect of Open-Angle Glaucoma Medications on Ocular Surface
February 17, 2020
MIGS Surgery to Manage Non-Adherence in Open-Angle Glaucoma
February 10, 2020
Importance of Adherence in Treatment of Open-Angle Glaucoma
February 10, 2020
Targeting MMP to Treat Open-Angle Glaucoma
February 03, 2020
Emerging Therapy for Open-Angle Glaucoma
February 03, 2020
Recently Approved Therapies to Treat Open-Angle Glaucoma
January 24, 2020
Monitoring IOP Fluctuations to Manage Open-Angle Glaucoma
January 24, 2020